CANF
Can-Fite BioPharma
CANF
CANF
15 hedge funds and large institutions have $950K invested in Can-Fite BioPharma in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Holders
15
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$819K | |
| 2 | +$20.3K | |
| 3 | +$16.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.79K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$778 |
Top Sellers
| 1 | -$22.6K | |
| 2 | -$20K | |
| 3 | -$14K | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$5.25K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$888 |
